Donors—absolute and relative differences in the number and value of payments
| All years | % | |
| Calculations based on the number of payments—absolute differences | ||
| Number of drug companies with at least one payment in at least one dataset—industry and patient organisation data | 87 | |
| Number of drug companies with exact match in both datasets | 3 | 3.4 |
| Number of drug companies with more payments in industry data | 49 | 56.3 |
| Number of drug companies with more payments in patient organisation data | 35 | 40.2 |
| Highest absolute difference between patient organisation and industry data—number of payments higher in industry data | 757 | |
| Highest absolute difference between patient organisation and industry data—number of payments higher in patient organisation data | 53 | |
| Calculations based on the number of payments—relative differences | ||
| Number of drug companies with relative difference <10% | 5 | 5.7 |
| Number of drug companies with relative difference <20% | 9 | 10.3 |
| Number of drug companies with relative difference <50% | 21 | 24.1 |
| Number of drug companies with relative difference=100% | 27 | 31.0 |
| Calculations based on the value of payments—absolute differences | ||
| Number of drug companies with at least one payment with value >£0 in at least one dataset | 74 | 100 |
| Number of drug companies with exact match in both datasets | 0 | 0.0 |
| Number of drug companies with higher payment value in industry data | 48 | 64.9 |
| Number of drug companies with higher payment value in patient organisation data | 26 | 35.1 |
| Highest absolute difference between patient organisation and industry data—number of payments higher in industry data (2016 £) | 6 406 351.2 | |
| Highest absolute difference between patient organisation and industry data—number of payments higher in patient organisation data (2016 £) | 2 960 716.0 | |
| Calculations based on the value of payments—relative differences | ||
| Number of drug companies with relative difference <10% | 3 | 4.1 |
| Number of drug companies with relative difference <20% | 9 | 12.2 |
| Number of drug companies with relative difference <50% | 14 | 18.9 |
| Number of drug companies with relative difference=100% | 24 | 32.4 |